» Articles » PMID: 38973469

Mass Spectrometry-intensive Top-down Proteomics: an Update on Technology Advancements and Biomedical Applications

Overview
Journal Anal Methods
Specialties Biochemistry
Chemistry
Date 2024 Jul 8
PMID 38973469
Authors
Affiliations
Soon will be listed here.
Abstract

Proteoforms are all forms of protein molecules from the same gene because of variations at the DNA, RNA, and protein levels, , alternative splicing and post-translational modifications (PTMs). Delineation of proteins in a proteoform-specific manner is crucial for understanding their biological functions. Mass spectrometry (MS)-intensive top-down proteomics (TDP) is promising for comprehensively characterizing intact proteoforms in complex biological systems. It has achieved substantial progress in technological development, including sample preparation, proteoform separations, MS instrumentation, and bioinformatics tools. In a single TDP study, thousands of proteoforms can be identified and quantified from a cell lysate. It has also been applied to various biomedical research to better our understanding of protein function in regulating cellular processes and to discover novel proteoform biomarkers of diseases for early diagnosis and therapeutic development. This review covers the most recent technological development and biomedical applications of MS-intensive TDP.

Citing Articles

Identifying putative allergens from Cenostigma pluviosum pollen using proteomic bioinformatics.

Neto J, Cavecci-Mendonca B, Olbrich S, Rocha F, Clemente E, Rossini B Mol Biol Rep. 2024; 51(1):1155.

PMID: 39542973 DOI: 10.1007/s11033-024-10079-6.


Proteomic insights into the extracellular matrix: a focus on proteoforms and their implications in health and disease.

Bains A, Naba A Expert Rev Proteomics. 2024; 21(11):463-481.

PMID: 39512072 PMC: 11602344. DOI: 10.1080/14789450.2024.2427136.


Proteomic Analysis of Fibroblasts Exposed to Resin Composite Release.

Flottes Y, Dursun E Proteomics Clin Appl. 2024; 19(1):e202400049.

PMID: 39422137 PMC: 11726277. DOI: 10.1002/prca.202400049.


The role of protein corona in advancing plasma proteomics.

Saei A, Sun L, Mahmoudi M Proteomics. 2024; 25(1-2):e2400028.

PMID: 39221533 PMC: 11735278. DOI: 10.1002/pmic.202400028.

References
1.
Wei B, Zenaidee M, Lantz C, Ogorzalek Loo R, Loo J . Towards understanding the formation of internal fragments generated by collisionally activated dissociation for top-down mass spectrometry. Anal Chim Acta. 2022; 1194:339400. PMC: 9088748. DOI: 10.1016/j.aca.2021.339400. View

2.
Jeong K, Kaulich P, Jung W, Kim J, Tholey A, Kohlbacher O . Precursor deconvolution error estimation: The missing puzzle piece in false discovery rate in top-down proteomics. Proteomics. 2023; 24(3-4):e2300068. DOI: 10.1002/pmic.202300068. View

3.
Wang C, Liang Y, Zhao B, Liang Z, Zhang L, Zhang Y . Ethane-Bridged Hybrid Monolithic Column with Large Mesopores for Boosting Top-Down Proteomic Analysis. Anal Chem. 2022; 94(16):6172-6179. DOI: 10.1021/acs.analchem.1c05234. View

4.
Yassine H, Trenchevska O, Ramrakhiani A, Parekh A, Koska J, Walker R . The Association of Human Apolipoprotein C-III Sialylation Proteoforms with Plasma Triglycerides. PLoS One. 2015; 10(12):e0144138. PMC: 4669142. DOI: 10.1371/journal.pone.0144138. View

5.
Tabb D, Jeong K, Druart K, Gant M, Brown K, Nicora C . Comparing Top-Down Proteoform Identification: Deconvolution, PrSM Overlap, and PTM Detection. J Proteome Res. 2023; 22(7):2199-2217. PMC: 10337255. DOI: 10.1021/acs.jproteome.2c00673. View